Dimethyl dicarbonate, VHC inhibitors in derivatives (4,4'bifeniilbis (1H-imidazol-4, 2-diil) -2, 1-pirroindil ((1S) -1-((2R, 6R) -2, 4-dimethydrohy-2H-piran-4-il) -2-oxo-2, 1-etandil)； intermediates； pharmacological synthesis； pharmacological combination； and use in tr Control of infection with VHC
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.COMPUESTOS DERIVADOS DE (4,4´-BIFENIILBIS(1H-IMIDAZOL-4,2-DIIL)-2,1-PIRROLIDINDIIL((1S)-1-((2R,6R)-2,4-DIMETILLTETRAHIDRO-2H-PIRAN-4-IL)-2-OXO-2,1-ETANDIIL)))BISCARBAMATO DE DIMETILO, INHIBIDORES DEL VHC； COMPUESTOS INTERMEDIARIOS； COMPOSICION FARMACEUTICA； COMBINACION FARMACEUTICA； Y USO PARA TRATAR UNA INFECCION POR VHC.
